Related Experiment Video

Updated: Aug 23, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

Three cases of central nervous system complications associated with Mycoplasma pneumoniae

Paul M Candler1, Russell C Dale

  • 1Department of Neuroinflammation, Institute of Neurology, University College London, London, United Kingdom.

Pediatric Neurology
|August 11, 2004
PubMed

Insights

Mycoplasma pneumoniae infection can trigger acute central nervous system diseases like encephalopathy and optic neuritis. These cases suggest a para-infectious immune response, not direct infection, leading to full recovery with steroid treatment.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Background:

  • Mycoplasma pneumoniae is a common respiratory pathogen.
  • Central nervous system (CNS) complications following M. pneumoniae infection are rare but serious.
  • The exact mechanism of CNS involvement remains debated, with theories including direct invasion or immune-mediated responses.

Observation:

  • Three new cases of acute CNS disease (encephalopathy, optic neuritis, transverse myelitis, seizures) occurred after M. pneumoniae infection.
  • Cerebrospinal fluid PCR for M. pneumoniae was negative in all patients, despite strong clinical evidence of preceding infection.
  • Patients presented with diverse neurological symptoms.

Findings:

  • The observed CNS manifestations are likely due to a para-infectious immune-mediated process rather than direct M. pneumoniae invasion of the CNS.
  • Rapid improvement was noted in patients treated with corticosteroids.
  • All three patients achieved full recovery.

Implications:

  • Distinguishing between immune-mediated and infectious mechanisms is crucial for effective treatment of M. pneumoniae-associated CNS disease.
  • This highlights the importance of considering post-infectious syndromes.
  • Further research is needed to elucidate the precise pathological pathways and optimize therapeutic strategies, potentially involving both antibiotics and immunomodulatory agents.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...